Russian government's censorship of websites with harm reduction methods for drug users helps fuel HIV epidemic, IPS reports

NewsGuard 100/100 Score

"A recent government crackdown on Russian media, particularly online information portals specializing in health tips and harm reduction methods for drug users, has sparked widespread public opposition, with critics claiming that the 'draconian silencing' of public health advocates could worsen an already perilous health situation in the country," Inter Press Service reports. "Given that Russia currently has one of the largest populations of injecting drug users in the world as well as one of the fastest growing HIV epidemics, the dissemination of such information is essential to keep the spread of the virus under control," IPS writes. "The fact that the United Nations listed universal treatment for people living with HIV/AIDS as one of its most urgent millennium development goals (MDGs) -- with a deadline of achieving universal treatment by 2015 -- human rights and health advocates contend that Russia's failure to allow information or services helpful to drug users breaches international human rights and public health laws," according to the news service (Klomegah, 2/17).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Breakthrough study offers hope for an effective HIV cure